trial · primary record
FISH OIL 500MG OMEGA-3 SOFT GEL MINIS
Dermatomyositis (DM)
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 3000 |
| Primary completion | 2031-11-03 |
| Primary endpoint | Reduction in DM/JDM disease activity, as assessed by the ACR EULAR Myositis Response Criteria Total Improvement Score, a composite assessment of change in myositis core set activity measures, between the O3FA vs. placebo groups. |
| Registry ID | NCT07111065 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:29.706Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07111065
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.